Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Kopp, KLM; Kauczok, CS; Lauenborg, B; Krejsgaard, T; Eriksen, KW; Zhang, Q; Wasik, MA; Geisler, C; Ralfkiaer, E; Becker, JC; Odum, N; Woetmann, A.
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF)
LEUKEMIA. 2010; 24(6): 1179-1185.
Doi: 10.1038/leu.2010.66
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Becker Jürgen Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Cancer often originates from a site of persistent inflammation, and the mechanisms turning chronic inflammation into a driving force of carcinogenesis are intensely investigated. Cyclooxygenase-2 (COX-2) is an inducible key modulator of inflammation that carries out the rate-limiting step in prostaglandin synthesis. Aberrant COX-2 expression and prostaglandin E(2) (PGE(2)) production have been implicated in tumorigenesis. In this study we show that COX-2 is ectopically expressed in malignant T-cell lines from patients with cutaneous T-cell lymphoma (CTCL) as well as in situ in lymphocytic cells in 21 out of 22 patients suffering from mycosis fungoides (MF) in plaque or tumor stage. COX-2 is not expressed in lymphocytes of 11 patients with patch-stage MF, whereas sporadic COX-2 staining of stromal cells is observed in the majority of patients. COX-2 expression correlates with a constitutive production of PGE(2) in malignant T cells in vitro. These cells express prostaglandin receptors EP3 and EP4 and the receptor antagonist as well as small interfering RNA (siRNA) directed against COX-2, and specific COX-2 inhibitors strongly reduce their spontaneous proliferation. In conclusion, our data indicate that COX-2 mediated PGE(2) exerts an effect as a tumor growth factor in MF.
- Find related publications in this database (using NLM MeSH Indexing)
-
Blotting, Western -
-
Cell Proliferation -
-
Cyclooxygenase 2 - chemistry Cyclooxygenase 2 - genetics Cyclooxygenase 2 - metabolism
-
Cyclooxygenase 2 Inhibitors - pharmacology
-
Enzyme-Linked Immunosorbent Assay -
-
Flow Cytometry -
-
Humans -
-
Immunoenzyme Techniques -
-
Lymphoma, T-Cell, Cutaneous - drug therapy Lymphoma, T-Cell, Cutaneous - metabolism Lymphoma, T-Cell, Cutaneous - pathology
-
Mycosis Fungoides - drug therapy Mycosis Fungoides - metabolism Mycosis Fungoides - pathology
-
Prostaglandins E - pharmacology
-
RNA, Messenger - genetics RNA, Messenger - metabolism
-
RNA, Small Interfering - pharmacology
-
Receptors, Prostaglandin E - metabolism
-
Receptors, Prostaglandin E, EP3 Subtype -
-
Reverse Transcriptase Polymerase Chain Reaction -
-
Skin Neoplasms - drug therapy Skin Neoplasms - metabolism Skin Neoplasms - pathology
-
Tumor Cells, Cultured -
- Find related publications in this database (Keywords)
-
COX-2
-
prostaglandin
-
CTCL
-
diagnosis
-
proliferation